HeraMED Limited (HMD.XA)
Cboe AU · AUD
A$0.036 (-10.00%) as of
Key statistics
- EPS (TTM)
- -0.0470
- 52-week range
- 0.0300 – 0.0540
- Beta
- 0.01
- Revenue (TTM)
- 330.44k
- Profit margin
- 0.00%
- Volume
- 517.86k
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
- Headquarters
- Hawthorn East, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.